1. Home
  2. GEHC vs CLS Comparison

GEHC vs CLS Comparison

Compare GEHC & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEHC
  • CLS
  • Stock Information
  • Founded
  • GEHC 1892
  • CLS 1994
  • Country
  • GEHC United States
  • CLS Canada
  • Employees
  • GEHC N/A
  • CLS N/A
  • Industry
  • GEHC Computer Software: Prepackaged Software
  • CLS Electrical Products
  • Sector
  • GEHC Technology
  • CLS Technology
  • Exchange
  • GEHC Nasdaq
  • CLS Nasdaq
  • Market Cap
  • GEHC 33.1B
  • CLS 37.1B
  • IPO Year
  • GEHC N/A
  • CLS 1998
  • Fundamental
  • Price
  • GEHC $73.46
  • CLS $295.89
  • Analyst Decision
  • GEHC Buy
  • CLS Strong Buy
  • Analyst Count
  • GEHC 9
  • CLS 13
  • Target Price
  • GEHC $86.11
  • CLS $308.77
  • AVG Volume (30 Days)
  • GEHC 3.9M
  • CLS 3.4M
  • Earning Date
  • GEHC 10-29-2025
  • CLS 10-27-2025
  • Dividend Yield
  • GEHC 0.19%
  • CLS N/A
  • EPS Growth
  • GEHC 32.35
  • CLS 103.66
  • EPS
  • GEHC 4.83
  • CLS 6.15
  • Revenue
  • GEHC $20,246,000,000.00
  • CLS $11,281,700,000.00
  • Revenue This Year
  • GEHC $6.41
  • CLS $25.61
  • Revenue Next Year
  • GEHC $4.44
  • CLS $31.72
  • P/E Ratio
  • GEHC $14.97
  • CLS $50.79
  • Revenue Growth
  • GEHC 3.51
  • CLS 22.09
  • 52 Week Low
  • GEHC $57.65
  • CLS $58.05
  • 52 Week High
  • GEHC $94.80
  • CLS $363.40
  • Technical
  • Relative Strength Index (RSI)
  • GEHC 47.81
  • CLS 46.71
  • Support Level
  • GEHC $70.04
  • CLS $297.50
  • Resistance Level
  • GEHC $75.59
  • CLS $324.80
  • Average True Range (ATR)
  • GEHC 1.93
  • CLS 24.03
  • MACD
  • GEHC -0.27
  • CLS -6.98
  • Stochastic Oscillator
  • GEHC 49.67
  • CLS 20.83

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

About CLS Celestica Inc.

Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

Share on Social Networks: